Postmarketing commitments include ongoing MASH outcome analyses, cardiovascular substudies, and continued pharmacovigilance for signals such as MTC, pancreatitis, severe GI events, renal injury, and aspiration events under anesthesia
Extra care is typically taken in individuals with: Certain thyroid conditions A history of pancreatitis Significant gastrointestinal disorders Pregnancy or breastfeeding A full medical evaluation helps determine whether retatrutide is appropriate and how dosing should be structured
This approval is a significant decision because people living with excess weight or obesity and established cardiovascular disease and without diabetes have never had an FDA-approved treatment option that lowers weight and reduces the likelihood of another cardiovascular event, said A Michael Lincoff (Cleveland Clinic, Cleveland, USA) and the lead study author of the SELECT outcomes trial
Check the packaging and labels A sure sign that youre dealing with a fake is misspellings on the label, or poor print quality
A 2024 study of more than 17,000 adults who had a BMI of more than 27 and heart disease revealed that those who took semaglutide continued to lose weight for 65 weeks